{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:07:14Z","timestamp":1790701634178,"version":"4.1.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02914","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T04:19:16Z","timestamp":1576124356000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":128,"title":["Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies"],"prefix":"10.3389","volume":"10","author":[{"given":"Silvia","family":"Franchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Moschetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sacerdote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.2174\/138161212803582496","article-title":"Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepressiono","volume":"18","author":"Sacerdote","year":"2012","journal-title":"Curr Pharm Design."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1111\/bph.13903","article-title":"Influence of opioids on immune function in patients with cancer pain: from bench to bedside","volume":"175","author":"Boland","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/bja\/aet153","article-title":"Opioids and immune modulation: more questions than answers","volume":"111","author":"Al-Hashimi","year":"2013","journal-title":"Br J Anaesth."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infection","volume":"83","author":"Risdahl","year":"1998","journal-title":"J Neuroimmunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","article-title":"Microbial infections, immunomodulation, and drugs of abuse","volume":"16","author":"Friedman","year":"2003","journal-title":"Clin Microbiol Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","article-title":"Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections","volume":"6","author":"Roy","year":"2011","journal-title":"J Neuroimmune Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/bjc.2014.384","article-title":"Effects of opioids on immunologic parameters that are relevant to antitumour immune potential in patients with cancer: a systematic literature review","volume":"111","author":"Boland","year":"2014","journal-title":"Br J Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am J Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/17425255.2019.1634053","article-title":"Opioids and the risk of infection: a critical appraisal of the pharmacologic and clinical evidence","volume":"15","author":"Khosrow-Khavar","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00726-011-1163-0","article-title":"Role of the mu-opioid receptor in opioid modulation of immune function","volume":"45","author":"Ninkovic","year":"2013","journal-title":"Amino Acids."},{"key":"B11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0002-9610(94)90070-1","article-title":"Perioperative immunomodulation in cancer surgery","volume":"167","author":"Colacchio","year":"1994","journal-title":"Am J Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2147\/JPR.S158230","article-title":"Immune function after major surgical interventions: the effect of postoperative pain treatment","volume":"111","author":"Amodeo","year":"2018","journal-title":"J Pain Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MCC.0000000000000213","article-title":"The perioperative immune response","volume":"21","author":"O'Dwyer","year":"2015","journal-title":"Curr Opin Crit Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0970-9185.129996","article-title":"Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: review of current evidence and practice","volume":"30","author":"Das","year":"2014","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"B15","first-page":"216","article-title":"Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients","volume":"14","author":"Kaye","year":"2014","journal-title":"Ochsner J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain."},{"key":"B17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000078444","article-title":"Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study","volume":"11","author":"Shavit","year":"2004","journal-title":"Neuroimmunomodulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/EJA.0b013e32832d540e","article-title":"Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages","volume":"27","author":"Forget","year":"2010","journal-title":"Eur J Anaesthesiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbi.2007.01.001","article-title":"Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment","volume":"21","author":"Franchi","year":"2007","journal-title":"Brain Behav Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbi.2014.06.011","article-title":"Dissociation of immunosuppressive and nociceptive effects of fentanyl, but not morphine, after repeated administration in mice: fentanyl induced sensitization to LPS","volume":"42","author":"Molina-Mart\u00ednez","year":"2014","journal-title":"Brain Behav Immun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00000542-200301000-00024","article-title":"Effects of preemptive analgesia on pain and cytokine production in the postoperative period","volume":"98","author":"Beilin","year":"2003","journal-title":"Anesthesiology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0192-0561(99)00025-9","article-title":"Effects of fentanyl on cellular immune functions in man","volume":"21","author":"Jacobs","year":"1999","journal-title":"Int J Immunopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/00000539-199603000-00011","article-title":"Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period","volume":"82","author":"Beilin","year":"1996","journal-title":"Anesth Analg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5055\/jom.2008.0005","article-title":"Relationship between fentanyl dosage and immune function in the postoperative period","volume":"4","author":"Yardeni","year":"2008","journal-title":"J Opioid Manage."},{"key":"B25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s00540-013-1597-5","article-title":"Comparative effects of flurbiprofen and fentanyl on natural killer cell cytotoxicity, lymphocyte subsets and cytokine concentrations in post-surgical intensive care unit patients: prospective, randomized study","volume":"27","author":"Narahara","year":"2013","journal-title":"J Anesth."},{"key":"B26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.7150\/ijms.20064","article-title":"The effects of perioperative anesthesia and analgesia on immune function in patients undergoing breast cancer resection: a prospective randomized study international","volume":"14","author":"Cho","year":"2017","journal-title":"J Med Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1213\/00000539-200201000-00018","article-title":"Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans","volume":"94","author":"Yeager","year":"2002","journal-title":"Anesth Analg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.hoc.2018.01.004","article-title":"Methadone: maximizing safety and efficacy for pain control in patients with cancer","volume":"32","author":"McPherson","year":"2018","journal-title":"Hematol Oncol Clin North Am."},{"key":"B29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s13181-018-0685-1","article-title":"Pharmacologic treatment of opioid use disorder: a review of pharmacotherapy, adjuncts, and toxicity","volume":"14","author":"Toce","year":"2018","journal-title":"J Med Toxicol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0300-483X(98)00077-8","article-title":"Effects of prolonged exposure to morphine and methadone on in vivo parameters of immune function in rats","volume":"129","author":"De Waal","year":"1998","journal-title":"Toxicology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/toxsci\/24.2.275","article-title":"The effect of methadone on the immune status of B6C3F1 mice","volume":"24","author":"LeVier","year":"1995","journal-title":"Fund Appl Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0192-0561(95)00010-Y","article-title":"Immunotoxicological screening of morphine and methadone in an extended 28 day study In Rats","volume":"6","author":"Van Der Laan","year":"1995","journal-title":"Int J Immunopharmnc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.intimp.2004.07.011","article-title":"Somogyi AA. (S)-(+)-methadone is more immunosuppressive than the potentanalgesic. (R)-(_)-methadone","volume":"4","author":"Hutchinson","year":"2004","journal-title":"Int Immunopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1734-1140(12)70916-7","article-title":"The influence of opioids on the humoral and cell-mediated immune responses in mice. The role of macrophages","volume":"64","author":"Filipczak-Bryniarska","year":"2012","journal-title":"Pharmacol Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2012.10.015","article-title":"Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function","volume":"255","author":"Kafami","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/bmjspcare-2013-000573","article-title":"A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function","volume":"4","author":"Boland","year":"2013","journal-title":"BMJ Support Palliat Care."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jp.2012.124","article-title":"Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells","volume":"33","author":"Chavez-Valdez","year":"2012","journal-title":"J Perinatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jneuroim.2013.07.012","article-title":"Mu opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes","volume":"263","author":"Borner","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1073\/pnas.76.11.5769","article-title":"Effects of opiates and demographic factors on DNA repair synthesis in human leukocytes","volume":"76","author":"Madden","year":"1979","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00213-005-2239-x","article-title":"Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","volume":"179","author":"Neri","year":"2005","journal-title":"Psychopharmacology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bbi.2007.12.013","article-title":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","volume":"22","author":"Sacerdote","year":"2008","journal-title":"Brain Behav Immun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis c incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction."},{"key":"B43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.intimp.2018.11.047","article-title":"Methadone therapy modulate the dendritic cells of heroin addicts","volume":"66","author":"Akbaria","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0122822","DOI":"10.1371\/journal.pone.0122822","article-title":"Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individuals","volume":"10","author":"Meijerink","year":"2015","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.psychres.2014.12.053","article-title":"Inflammatory response in heroin addicts undergoing methadone maintenance treatment","volume":"226","author":"Chan","year":"2015","journal-title":"PsychiatryRes."},{"key":"B46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.tips.2013.02.001","article-title":"Does the pharmacology of oxycodone justify its increasing use as an analgesic?","volume":"34","author":"Olkkola","year":"2013","journal-title":"Trends Pharmacol Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br J Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.intimp.2017.11.039","article-title":"In contrast to morphine, buprenorphine enhances macrophage-induced humoral immunity, and as oxycodone, slightly suppresses the effector phase of cell-mediated immune response in mice","volume":"54","author":"Filipczak-Bryniarska","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.dib.2017.12.017","article-title":"Data supporting the understanding of modulatory function of opioid analgesics in mouse macrophage activity","volume":"16","author":"Filipczak-Bryniarska","year":"2018","journal-title":"Data in Brief."},{"key":"B50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejphar.2004.04.049","article-title":"Relationship between 4,5-epoxymorphinan structure and in vitro modulation of cell proliferation","volume":"494","author":"Hutchinson","year":"2004","journal-title":"Eur J Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1399-6576.2004.00404.x","article-title":"Effects of post-operative pain treatment using non-steroidal anti-inflammatory analgesics, opioids or epidural blockade on systemic and local immune responses in children","volume":"48","author":"Vuori","year":"2004","journal-title":"Acta Anaesthesiol Scand."},{"key":"B52","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/1049909112469823","article-title":"Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain","volume":"30","author":"Suzuki","year":"2012","journal-title":"Am J Hospice Palliat Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/MD.0000000000007519","article-title":"Effects of oxycodone on immune function in patients undergoing radical resection of rectal cancer under general anesthesia","volume":"96","author":"Cui","year":"2017","journal-title":"Medicine."},{"key":"B54","first-page":"3","article-title":"Basic pharmacology of buprenorphine","volume-title":"Buprenorphine-the Unique Opioid Analgesic.","author":"Cowan","year":"2005"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1080\/14656566.2016.1244529","article-title":"Update on pharmacotherapy for treatment of opioid use disorder","volume":"17","author":"Ayanga","year":"2016","journal-title":"Expert Opin Pharmacother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1521-6616(03)00177-3","article-title":"No detrimental effect from chronic exposure to buprenorphine on corticosteroid- binding globulin and corticosensitive immune parameters","volume":"109","author":"D'Elia","year":"2003","journal-title":"Clin Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jpainsymman.2005.01.006","article-title":"Immunologic effects of opioids in the presence or absence of pain","volume":"29","author":"Page","year":"2005","journal-title":"J Pain Symptom Manage."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.4049\/jimmunol.1302647","article-title":"Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes","volume":"194","author":"Carvallo","year":"2015","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/JLB.3HI0118-015R","article-title":"Frontline science: buprenorphine decreases CCL2-mediated migration of CD14(+) CD16(+) monocytes","volume":"104","author":"Jaureguiberry-Bravo","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2165\/00003495-200565130-00007","article-title":"Remifentanil: a review of its use during the induction and maintenance of general anaesthesia","volume":"65","author":"Scott","year":"2005","journal-title":"Drugs."},{"key":"B62","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S1567-5769(01)00005-4","article-title":"Effect of the opioid remifentanil on cellular immune response in the rat","volume":"1","author":"Sacerdote","year":"2001","journal-title":"Int Immunopharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1538\/expanim.17-0121","article-title":"Remifentanil attenuates lipopolysaccharide-induced acute lung injury by downregulating the NF-\u03baB signaling pathway","volume":"37","author":"Zhang","year":"2014","journal-title":"Inflammation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10753-014-9893-2","article-title":"Remifentanil attenuates human neutrophils activation induced by lipopolysaccharide","volume":"35","author":"Hyejin","year":"2013","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1034\/j.1399-6576.2000.441008.x","article-title":"Effects of remifentanil on neutrophil adhesion, transmigration, and intercellular adhesion molecule expression","volume":"44","author":"Hofbauer","year":"2000","journal-title":"Acta Anaesthesiol Scand."},{"key":"B66","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/bja\/aeg273","article-title":"Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers","volume":"91","author":"Cronin","year":"2003","journal-title":"Br J Anaesth."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1177\/147323000803600610","article-title":"Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery","volume":"36","author":"von Dossow","year":"2008","journal-title":"J Int Med Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/17460441.2017.1377697","article-title":"Discovery and development of tramadol for the treatment of pain","volume":"12","author":"Bravo","year":"2017","journal-title":"Expert Opin Drug Discov."},{"key":"B69","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0304-3959(97)00055-9","article-title":"Effects of tramadol on immune responses and nociceptive thresholds in mice","volume":"72","author":"Sacerdote","year":"1997","journal-title":"Pain."},{"key":"B70","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0192-0561(99)00048-X","article-title":"Effects of tramadol and its enantiomers on concanavalin-A induced proliferation and NK activity of mouse splenocytes: involvement of serotonin","volume":"21","author":"Sacerdote","year":"1999","journal-title":"Int J Immunopharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0304-3959(00)00472-3","article-title":"Effects of tramadol on T lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury","volume":"92","author":"Tsai","year":"2001","journal-title":"Pain."},{"key":"B72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0165-5728(02)00165-0","article-title":"The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats","volume":"129","author":"Gaspani","year":"2002","journal-title":"J Neuroimmunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth Analg."},{"key":"B74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cca.2006.01.008","article-title":"Which has the least immunity depression during postoperative analgesia\u2013morphine, tramadol, or tramadol with lornoxicam?","volume":"369","author":"Wang","year":"2006","journal-title":"Clin Chim Acta."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/BF03021601","article-title":"Tramadol does not impair the phagocytic capacity of human peripheral blood cells","volume":"52","author":"Beilin","year":"2005","journal-title":"Can J Anaesth."},{"key":"B76","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1533-2500.2011.00487.x","article-title":"Current considerations for the treatment of severe chronic pain: the potential for tapentadol","volume":"12","author":"Pergolizzi","year":"2012","journal-title":"Pain Pract."},{"key":"B77","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/11589080-000000000-00000","article-title":"Tapentadol in pain management: a \u03bc-opioid receptor agonist and noradrenaline reuptake inhibitor","volume":"25","author":"Hartrick","year":"2011","journal-title":"CNS Drugs."},{"key":"B78","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1213\/ANE.0000000000001669","article-title":"Effect of tapentadol on splenic cytokine production in mice","volume":"124","author":"Franchi","year":"2017","journal-title":"Anesth Analg."},{"key":"B79","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1073\/pnas.95.11.6326","article-title":"Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene","volume":"95","author":"Gav\u00e9riaux-Ruff","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0169-328X(98)00051-5","article-title":"mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit","volume":"56","author":"Roy","year":"1998","journal-title":"Brain Res Mol Brain Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/j.bja.2019.03.006","article-title":"Hot topics in opioid pharmacology: mixed and biased opioids","volume":"122","author":"Azzam","year":"2019","journal-title":"Br J Anaesth."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","article-title":"Advances in achieving opioid analgesia without side effects","volume":"9","author":"Machelska","year":"2018","journal-title":"Front Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/mol.119.115956","article-title":"A biased view of \u03bc opioid receptors?","volume":"97","author":"Conibear","year":"2019","journal-title":"Mol Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2174\/0929867326666190506103124","article-title":"Biased agonism as an emerging strategy in the search for better opioid analgesics","volume":"5","author":"Janecka","year":"2019","journal-title":"Curr Med Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"","journal-title":"Cell."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s40265-018-0953-z","article-title":"Treating chronic pain: an overview of clinical studies centered on the buprenorphine option","volume":"78","author":"Davis","year":"2018","journal-title":"Drugs."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1744806916654146","article-title":"Characterization of methadone as a b-arrestin-biased k-opioid receptor agonist","volume":"12","author":"Doi","year":"2016","journal-title":"Mol Pain."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0002-9440(10)61220-5","article-title":"Morphine withdrawal enhances hepatitis C virus replicon expression","volume":"167","author":"Wang","year":"2005","journal-title":"Am J Pathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1189\/jlb.0304123","article-title":"Splenic macrophages and B cells mediate immunosuppression following withdrawal from morphine","volume":"78","author":"Rahim","year":"2005","journal-title":"J Leukoc Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-4615-2980-4_4","article-title":"Consequences of opiate-dependency in a monkey model of AIDS","volume":"373","author":"Donahoe","year":"1993","journal-title":"Adv Exp Med Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jneuroim.2003.10.011","article-title":"Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model","volume":"147","author":"Donahoe","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1086\/433175","article-title":"The role of substance of abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations","volume":"41","author":"Kapadia","year":"2004","journal-title":"Clin Infect Dis."},{"key":"B93","first-page":"205","article-title":"Rational for maintenance pharmacotherapy of opiate dependence","author":"Kreek","year":"1992"},{"key":"B94","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.psychres.2006.02.013","article-title":"Experimentally induced aggressiveness in heroindependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects","volume":"149","author":"Gerra","year":"2007","journal-title":"Psychiatry Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jclinane.2005.03.004","article-title":"Effects of morphine and its metabolites on immune function in advanced cancer patients","volume":"17","author":"Hashiguchi","year":"2005","journal-title":"J Clin Anesth."},{"key":"B96","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1567-5769(01)00020-0","article-title":"Morphine-6 beta-glucuronide induces potent immunomodulation","volume":"1","author":"Carrigan","year":"2001","journal-title":"Int Immunopharmacol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02914\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T04:19:19Z","timestamp":1576124359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02914\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":96,"alternative-id":["10.3389\/fimmu.2019.02914"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02914","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"article-number":"2914"}}